Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation.
Costanzo-Nordin, M R
Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation. [electronic resource] - The Journal of heart transplantation - 306-15 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0887-2570
Animals
Antibodies, Monoclonal--therapeutic use
Antilymphocyte Serum--therapeutic use
Female
Graft Rejection
Heart Transplantation
Horses
Humans
Immunosuppression Therapy
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Muromonab-CD3
Prospective Studies
Randomized Controlled Trials as Topic
T-Lymphocytes--immunology
Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation. [electronic resource] - The Journal of heart transplantation - 306-15 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0887-2570
Animals
Antibodies, Monoclonal--therapeutic use
Antilymphocyte Serum--therapeutic use
Female
Graft Rejection
Heart Transplantation
Horses
Humans
Immunosuppression Therapy
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Muromonab-CD3
Prospective Studies
Randomized Controlled Trials as Topic
T-Lymphocytes--immunology